Allergan Asks 9th Circ. To Ignore Atty's Claims Of Fraud
Allergan has urged the Ninth Circuit to uphold a California federal court's decision to toss a suit from a patent litigator concerning claims of fraudulently landing dementia drug patents, arguing that the...To view the full article, register now.
Already a subscriber? Click here to view full article